Table of Contents |
| Preface | v |
| List of Contributing Authors | xi |
1. | Ceramic polymer composites for hard tissue applications / Chandra P. Sharma | 1 |
1.1. | Introduction | 1 |
1.2. | Polyethylene based composites | 3 |
1.3. | Polymethymethacrylate based composites | 6 |
1.4. | Polyester based composites | 7 |
1.5. | Chitosan based composites | 10 |
1.6. | Future Scope | 11 |
1.7. | Conclusion | 12 |
| References | 12 |
2. | HAp-metal based biocomposite coatings and characteristics of plasma-deposited HAp-Ti/Ti6Al4V coatings / Ramesh K. Guduru | 17 |
2.1. | Introduction | 17 |
2.2. | HAp-Ti/Ti6Al4V based composites | 18 |
2.2.1. | Hydroxyapatite (HAp) | 18 |
2.2.2. | Titanium and its alloys | 19 |
2.3. | Plasma Spray of HAp-Ti/Ti6Al4V based composites | 20 |
2.4. | Property requirement of biocomposites | 21 |
2.4.1. | Mechanical properties | 22 |
2.4.2. | Biocompatibility | 22 |
2.4.3. | Bioactivity | 23 |
2.5. | Property evaluation | 23 |
2.5.1. | Bond strength | 23 |
2.5.2. | Corrosion behavior evaluation | 24 |
2.5.3. | Immersion test in simulated body fluid | 24 |
2.6. | Plasma sprayed HAp-(Ti/Ti6Al4V) based composite coatings | 25 |
2.6.1. | Bond strength of plasma-sprayed HAp-(Ti/Ti6Al4V) based composite coatings | 25 |
2.6.2. | Electrochemical corrosion behavior of plasma-sprayed HAp-(Ti/Ti6Al4V) based composite coatings | 27 |
2.6.3. | Immersion behavior of plasma sprayed HAp-(Ti/Ti6Al4V) based composite coatings | 27 |
2.7. | Conclusions | 29 |
| References | 29 |
3. | Hydrogels based on poly(vinylalcohol) for cartilage replacement / Jimena S. Gonzalez | 33 |
3.1. | Hydrogels: General Ideas | 33 |
3.2. | Main properties of hydrogels | 34 |
3.3. | Hydrogels as biomaterials | 37 |
3.4. | Polyvinyl alcohol (PVA) hydrogels: General characteristics | 38 |
3.5. | PVA hydrogels for biomedical applications | 40 |
3.6. | Cartilage: A brief description | 41 |
3.7. | Articular cartilage: Architecture and composition | 41 |
3.8. | Articular cartilage: Mechanical properties | 43 |
3.9. | Frequent medical issues relating to cartilage: Degeneration and osteoarthritis | 44 |
3.10. | Materials used as articular replacement | 44 |
| Conclusions | 46 |
| Acknowledgments | 46 |
| References | 46 |
4. | Polymer composites for cemented total hip replacements / S. Kanagaraj | 53 |
4.1. | Introduction | 53 |
4.1.1. | Understanding hip joint prosthesis and fixation techniques | 53 |
4.1.2. | Economic and clinical factors surrounding revision surgeries | 56 |
4.2. | UHMWPE composites | 57 |
4.3. | PMMA composites | 60 |
| Summary | 63 |
| Future scope | 63 |
| References | 64 |
5. | Bioresorbable composites for bone repair / Jose M.F. Ferreira | 69 |
5.1. | Introduction | 69 |
5.2. | Bioresorbable materials | 73 |
5.2.1. | Polymers | 73 |
5.2.1.1. | Polyglycolic acid -- PGA | 73 |
5.2.1.2. | Polylactic acid -- PLA | 74 |
5.2.1.3. | PGA-PLA copolymers | 76 |
5.2.1.4. | Poly ε-caprolactone -- PCL | 76 |
5.2.2. | Bioactive ceramics | 77 |
5.3. | Composites manufacturing methods | 78 |
5.4. | Clinical applications of bioresorbable composites for bone repair | 79 |
5.5. | Conclusions | 80 |
| References | 81 |
6. | Bioactive glasses and glass-ceramics / H. Doweidar | 89 |
6.1. | Biodental metals, ceramics and bioactive glass-ceramics; historical background | 89 |
6.2. | Metallic implant materials | 89 |
6.2.1. | Gold alloys | 90 |
6.2.2. | Dental amalgam | 90 |
6.3. | Glass-ceramics and bioactive glass-ceramics | 90 |
6.3.1. | Commercial glass-ceramic products | 91 |
6.3.2. | Protective glass-ceramic | 91 |
6.3.3. | Bioceramics | 92 |
6.4. | Preparation techniques | 92 |
6.5. | Structure of glass-ceramics | 94 |
6.6. | Crystallinity enhancement | 96 |
6.6.1. | By adding activator agents | 96 |
6.6.2. | By sintering process | 98 |
6.7. | Dental glass-ceramics | 98 |
6.8. | Bioactive glass-ceramics | 99 |
6.9. | In vitro and in vivo test for bioactivity | 101 |
| References | 104 |
7. | Metal oxide-based one-dimensional titania nanostructures via electrospinning: Characterization and antimicrobial applications / Myung-Seob Khil | 107 |
7.1. | Introduction | 107 |
7.2. | General routes/procedures for the synthesis of nanofibers | 109 |
7.3. | Electrospinning process | 109 |
7.4. | General applications of electrospun nanofibers | 111 |
7.5. | Antimicrobial applications of metal oxide-based nanotextured materials/nanofibers | 112 |
7.6. | Concept of doping and composite nanofibers | 113 |
7.7. | Development of pristine TiO2 nanofibers via electrospinning technique | 114 |
7.8. | Doping of titania with metal oxide | 117 |
7.8.1. | Doping of titania with zinc | 117 |
7.8.2. | Doping of titania with copper | 121 |
7.8.3. | Doping of titania with nickel | 124 |
7.8.4. | Doping of titania with cobalt | 126 |
7.8.5. | Doping of titania with cerium | 128 |
7.9. | Plausible antibacterial mechanism of TiO2 / doped-TiO2 nanostructures | 131 |
7.10. | Concluding remarks | 133 |
| Acknowledgment | 134 |
| References | 134 |
8. | Hydrogels for biomedical applications / Assunta Borzacchiello | 141 |
8.1. | Hydrogels: Classification and basic structure | 141 |
8.1.1. | In situ forming hydrogels | 143 |
| Physical crosslinking methods | 143 |
| Covalent crosslinking strategies for forming hydrogels in situ | 146 |
8.2. | Structure-properties relationship | 147 |
8.2.1. | Hydrogel mechanical properties | 147 |
| Hydrogels' time dependent properties | 147 |
| Stress strain behavior | 149 |
8.2.2. | Hydrogel swelling | 150 |
8.3. | Biomedical applications | 152 |
8.3.1. | Tissue engineering | 152 |
8.3.2. | Drug delivery | 155 |
8.3.2.1. | Design criteria for hydrogels in drug delivery | 156 |
| Incorporation of drugs | 157 |
8.3.2.2. | Drugs release from hydrogels formulations | 158 |
| Dynamic hydrogels | 159 |
| Composite hydrogels | 160 |
| Micro-nanoscale hydrogels | 160 |
| In situ forming hydrogel | 161 |
| References | 162 |
| Index | 169 |